AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)

CUSIP: 00847X104

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 6 signals
Share change
+1,434
SEC-reported price per share
$37.11
Number of holders
2
Value change
+$53,216
Number of buys
1
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
59,490,804

Security key

00847X104

Report period

Q2 2026

Institutions

2

Top holders

4

Ownership snapshot

Top reported holders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Farallon Capital Partners...
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
25 Jun 2026
13D/G 13F Lead comparable stake: 8.8% 13D/G row: Farallon Capital Partners, L.P. Showing 1-6 of 15 holder rows.

Quick read

Farallon Capital Partners, L.P. leads the comparable SEC ownership view at 8.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Farallon Capital Partners, L.P.'s linked filing trail.
Comparable ownership Top 5
Farallon Capital Partners, L.P. 8.8%
BlackRock, Inc. 7.8%
STATE STREET CORP 5.3%
VANGUARD CAPITAL MANAGEMENT LLC 5.3%
Lynx1 Capital Management LP 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Farallon Capital Partners, L.P.
13D/G
Dapice Joshua J.
8.8%
$146,117,182
5,159,505 shares
-$14,583,696 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
7.8%
from 13D/G
$194,690,195
5,754,957 shares
31 Mar 2026
STATE STREET CORP
13F 13D/G
Company · STATE STREET CORPORATION
5.3%
from 13D/G
$113,719,376
3,364,879 shares
31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
5.3%
$104,472,757
3,088,169 shares
$0 31 Mar 2026
Lynx1 Capital Management LP
13D/G 13F
Company
5.1%
$105,819,749
3,013,949 shares
$0 29 Apr 2026
D. E. SHAW & CO, L.P.
13D/G
5.1%
$85,832,737
3,034,031 shares
$0 25 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
2,539
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
230
Q2 2026 holders
2
Holder diff
-228
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .